Literature DB >> 2836384

Activation of the epidermal growth factor receptor tyrosine protein kinase in the absence of receptor oligomerization.

I C Northwood1, R J Davis.   

Abstract

The epidermal growth factor (EGF) receptor exists in a monomeric (170 kDa) form and in several aggregated states (360 kDa, greater than 500 kDa). The hypothesis that the oligomerization of the receptor is required for the stimulation of the kinase was tested by correlating the oligomeric state of the receptor with the protein kinase activity. EGF and sphingosine stimulate the phosphorylation of an exogenous peptide substrate by the receptor to an equal extent. Chemical cross-linking using disuccinimidyl suberate and the analysis of EGF receptor complexes by Western blotting demonstrated that EGF caused the aggregation of receptors. Similar results were obtained when [32P]phosphate-labeled receptors were cross-linked using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride. These results were confirmed by sucrose density gradient sedimentation analysis. In contrast to the effects of EGF, incubation of EGF receptors with sphingosine did not cause the oligomerization of the receptors. These data demonstrate that the EGF receptor kinase can be stimulated independently of the aggregation of the receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836384

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions.

Authors:  M A Adelsman; B K Huntley; N J Maihle
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

2.  Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation.

Authors:  A Basu; M Raghunath; S Bishayee; M Das
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

Review 3.  A new turning point in glycosphingolipid research.

Authors:  Masao Iwamori
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

4.  Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).

Authors:  C T Chu; K D Everiss; C J Wikstrand; S K Batra; H J Kung; D D Bigner
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

Review 5.  Cell regulation by sphingosine and more complex sphingolipids.

Authors:  A H Merrill
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

6.  Physicochemical characterization of the cytoplasmic domain of the epidermal growth factor receptor and evidence for conformational changes associated with its activation by ammonium sulphate.

Authors:  M Gregoriou; P F Jones; J F Timms; J J Yang; S E Radford; A R Rees
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

7.  Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.

Authors:  T Hashizume; T Sato; T Fujii
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

8.  Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor.

Authors:  R L Woltjer; T J Lukas; J V Staros
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Transmembrane peptides as inhibitors of ErbB receptor signaling.

Authors:  Amar Bennasroune; Maria Fickova; Anne Gardin; Sylvie Dirrig-Grosch; Dominique Aunis; Gérard Crémel; Pierre Hubert
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

10.  Heparin alters epidermal growth factor metabolism in cultured rat glomerular epithelial cells.

Authors:  S Adler
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.